2012 ©
             Publication
Journal Publication
Research Title Effect of Albumin on In Vitro Omeprazole Kinetics in Human Liver Microsomes 
Date of Distribution 10 May 2009 
Conference
     Title of the Conference 3rd Asian Pacific Regional Meeting : Understanding Xenobiotics for Better Drug Development and Therapy 
     Organiser ISSX : International Society for the Study of Xenobiotics 
     Conference Place The imperial Queen's Park Hotel 
     Province/State กรุงเทพมหานคร 
     Conference Date 10 May 2009 
     To 12 May 2009 
Proceeding Paper
     Volume 41 
     Issue
     Page 32 
     Editors/edition/publisher Jack A. Hinson 
     Abstract Omeprazole (OMP) is metabolised by CYP2C19 and CYP3A4 to 5-hydroxyomeprazole and omeprazole sulfone, respectively. It has been demonstrated that polyunsaturated fatty acids (PUFAs) are substrates and potent inhibitors of CYP2C19. We hypothesise that the addition of bovine serum albumin (BSA) to incubations of human liver microsomes (HLM) will sequester PUFAs that are released from the membranes of HLM during the course of incubation, therefore providing true estimates of kinetic parameters. This study investigated the effect of BSA on the kinetics of OMP 5-hydroxylation and sulfoxidation by microsomes from 5 human livers. In the absence of BSA, 5-hydroxyomeprazole and omeprazole sulfone formation followed two enzyme Michaelis-Menten kinetics. The mean apparent (± S.D.) kinetic parameters for OMP 5-hydroxylation were: Km1= 8.63 ± 6.83 mM, Vmax1 = 97.3 ± 46.7 pmol/min.mg and CLint1 = 13.8 ± 8.39 mL/min.mg; Km2 = 156 ± 123 mM, Vmax2 = 239 ± 77.4 pmol/min.mg and CLint2 = 2.34 ± 1.47 mL/min.mg. The mean apparent (± S.D.) kinetic parameters for OMP sulfoxidation were: Km1= 16.5 ± 11.5 mM, Vmax1 = 63.0 ± 60.2 pmol/min.mg and CLint1 = 3.16 ± 1.50 mL/min.mg; Km2 = 195 ± 105 mM, Vmax2 = 240 ± 116 pmol/min.mg and CLint2 = 1.38 ± 0.54 mL/min.mg. In the presence of 2% BSA, 5-hydroxyomeprazole formation also followed two enzyme Michaelis-Menten kinetics whereas omeprazole sulfone formation followed a single enzyme Michaelis-Menten model. In the presence of 2% BSA, the Km1 and Vmax1 for OMP 5-hydroxylation were significantly reduced (2 to 4 fold) consequently CLint1 was increased (2 fold). Hence, the addition of BSA to the reaction incubations had minor effect on the CYP2C19 catalysed high affinity component (Km1 and Vmax1) of OMP 5-hydroxylation, whereas the effect of BSA on OMP sulfoxidation was less clear. Further investigations of the effect of BSA on OMP 5-hydroxylation and sulfoxidation by recombinant CYP2C19 and CYP3A4 are required to clarify the role of BSA on in vitro OMP kinetics. 
Author
497070007-7 Miss NITSUPA WATTANACHAI [Main Author]
Medicine Doctoral Degree

Peer Review Status มีผู้ประเมินอิสระ 
Level of Conference นานาชาติ 
Type of Proceeding Abstract 
Type of Presentation Poster 
Part of thesis true 
Presentation awarding false 
Attach file
Citation 0